Asthma was first described in the medical literature of Greek antiquity. It is difficult to determine whether by referring to “asthma”, Hippocrates and his school (460-360 B.C.) meant an autonomous clinical entity or a symptom. The clinical presentation of asthma nowadays has probably changed little compared to 200 years ago. However, there are now many more people with asthma. According to the Global Initiative for Asthma: ‘Asthma is a disorder defined by its clinical, physiological, and pathological characteristics. The predominant feature of the clinical history is episodic shortness of breath, particularly at night, often accompanied by cough. Wheezing appreciated on auscultation of the chest is the most common physical finding. The main physiological feature of asthma is episodic airway obstruction characterized by expiratory airflow limitation. The dominant pathological feature is airway inflammation, sometimes associated with airway structural changes (www.ginasthma.org).’ In Western countries the prevalence of childhood asthma and atopic diseases has increased dramatically during the end of the last century. There are large differences in asthma prevalence between Western countries, and between the different continents. In Western countries, asthma is one of the most frequent chronic disorders in childhood, with a high burden of morbidity, absenteeism from school, health care costs and reduced quality of life.

, , ,
The PIAMA study is supported by the Netherlands Organisation for Health Research and Development, the Netherlands Organisation for Scientific Research, the Netherlands Asthma Fund, the Netherlands Ministry of Spatial Planning, Housing, and the Environment, and the Netherlands Ministry of Health, Welfare and Sport. The CHARISM study was funded by Aerocrine AB, Solna, Sweden. The general design of Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development (ZonMw), the Netherlands Organisation for Scientific Research (NWO), the Ministry of Health, Welfare and Sport and the Ministry of Youth and Families. The printing of this thesis has been financially supported by the Erasmus University Rotterdam, the Generation R Study Group Rotterdam, the J.E. Jurriaanse Stichting and Stichting Astma Bestrijding. Further financial support for this dissertation was kindly provided by Abbott BV, ALK-Abelló BV, BD Biosciences, Boehringer Ingelheim BV, ChipSoft BV, Danone Research – Centre for Specialised Nutrition, GlaxoSmithKline BV, Teva Nederland BV and Thermo Fisher Scientific.
A. Hofman (Albert) , J.C. de Jongste (Johan)
Erasmus University Rotterdam
hdl.handle.net/1765/39547
Erasmus MC: University Medical Center Rotterdam

van der Valk, R. (2013, April 12). Exhaled nitric oxide and asthma in childhood. Retrieved from http://hdl.handle.net/1765/39547